DCX and acute myeloid leukemia: Gene Set Enrichment Analysis (GSEA) of DC-STAMP-high AML samples [10] revealed marked activation of the mTORC1 signaling pathway, suggesting that DC-STAMP activation may upregulate mTORC1 to promote malignant proliferation and suppress PANoptosis, thereby accelerating AML progression and chemoresistance.